Author(s):
Mayuri N. Jagtap, Prerana T. Borade, Sayali V. Bodake, Avinash B. Darekar
Email(s):
mayurinjagtap185@gmail.com
DOI:
10.52711/2231-5691.2024.00046 
Address:
Mayuri N. Jagtap*, Prerana T. Borade, Sayali V. Bodake, Avinash B. Darekar
1Department of Pharmacy, K.V.N. Naik SPS’s Institute of Pharmaceutical Education and Research, Nashik - 422003, Maharashtra, India.
2Department of Pharmacology, K.V.N. Naik SPS’s Institute of Pharmaceutical Education and Research, Nashik - 422003, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 3,
Year - 2024
ABSTRACT:
Since the Nipah virus's discovery two decades ago, a great deal of knowledge has been applied to the virus's genome, pathology, and wide selectivity of transmission. The highly lethal zoonotic paramyxovirus known as the Nipah virus was first identified in Malaysia in 1998. It's a pathogen that is intimate enough to cause encephalitis caused by the current respiratory virus. The key to controlling discharge is the proactive diagnosis and use of virus management techniques. Only a small number of the 14 bat species found in Malaysia have been identified as vectors of viral transmission, affecting humans, horses, cats, dogs, and pigs. The review provides an explanation of the recent NIV outbreaks in the Philippines, Malaysia, Singapore, Bangladesh, and India. The method of transmission, the preventative and control measures used, and the available evidence following the outbreaks. The virus can also inadvertently result in large financial losses for farmers by seriously sickening animals like pigs. Additionally, it can spread from person to person. Non-invasive ventilation (NIV) is seen in the bronchiole epithelial cells during the early stages of human collapse. The anti-NIV specific IgM was found using the fastest ELISA assay, while the IgG antibody was found using an incidental IgG ELISA. These findings highlight the role that viral glycoproteins play in eliciting neutralizing antibodies, which act as potential vaccines to protect against the illness. Furthermore, there's a chance that these vaccinations will provide cross-protection against similarly related viruses.
Cite this article:
Mayuri N. Jagtap, Prerana T. Borade, Sayali V. Bodake, Avinash B. Darekar. Enhancing the science in the Global transmission of Nipah virus. Asian Journal of Pharmaceutical Research. 2024; 14(3):295-2. doi: 10.52711/2231-5691.2024.00046
Cite(Electronic):
Mayuri N. Jagtap, Prerana T. Borade, Sayali V. Bodake, Avinash B. Darekar. Enhancing the science in the Global transmission of Nipah virus. Asian Journal of Pharmaceutical Research. 2024; 14(3):295-2. doi: 10.52711/2231-5691.2024.00046 Available on: https://asianjpr.com/AbstractView.aspx?PID=2024-14-3-15
REFERENCES:
1. Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. The Lancet. 1999 Oct 9; 354(9186): 1257-9. https://doi.org/10.1016/S0140-6736(99)04299-3
2. Kulkarni DD, Tosh C, Venkatesh G, Senthil Kumar D. Nipah virus infection: current scenario. Indian Journal of Virology. 2013 Dec; 24(3): 398-408. DOI 10.1007/s13337-013-0171-y.
3. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra AC. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerging infectious diseases. 2006 Feb; 12(2): 235. DOI: 10.3201/eid1202.051247
4. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh WJ, Goldsmith CS. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000 May 26; 288(5470): 1432-5. DOI: 10.1126/science.288.5470.1432
5. Ensuring M. New viruses fingered in Malaysia epidemic DOI: 10.1126/science.284.5413.407
6. Centres for Disease Control and Prevention (CDC. Update: outbreak of Nipah virus--Malaysia and Singapore, 1999. MMWR. Morbidity and Mortality Weekly Report. 1999 Apr 30; 48(16): 335-7. PMID: 10366143
7. 8 Paton NI, Leo YS, Zaki SR, Auch us AP, Lee KE, Ling AE, Chew SK, Ang B, Rollin PE, Umapathi T, Sang I. Outbreak of Nipah-virus infection among abattoir workers in Singapore. The Lancet. 1999 Oct 9; 354(9186): 1253-6. DOI: 10.1016/S0140-6736(99)04379-2
8. Shariff M. Nipah virus infection: A review. Epidemiology and Infection. 2019;147: e95. DOI: 10.1017/S0950268819000086
9. Banerjee A, Kulcsar K, Misra V, Frieman M, Mossman K. Bats and coronaviruses. Viruses. 2019 Jan 9; 11(1): 41. DOI: 10.3390/v11010041
10. Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH, Rahman SA, Hughes T, Smith C, Field HE, Dastak P. Pteropod bats are confirmed as the reservoir hosts of heptaverines: a comprehensive experimental study of virus transmission. The American Journal of Tropical Medicine and Hygiene. 2011 Nov 11; 85(5): 946. DOI: 10.4269/ajtmh.2011.10-0567
11. Chow VT, Tambiah PA, Yeo WM, Phoon MC, Howe J. Diagnosis of Nipah virus encephalitis by electron microscopy of cerebrospinal fluid. Journal of Clinical Virology. 2000 Oct 1; 19(3): 143-7. Doi: 10.1007/s13337-013-0171-y
12. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra AC. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerging Infectious Diseases. 2006 Feb; 12(2): 235. DOI: 10.3201/eid1202.051247
13. World Health Organization. List of Blueprint priority diseases. R&D Blueprint. World Health Organization. 2018 Nov. DOI: 10.1016/j.antiviral.2018.09.009
14. Chua KB. Nipah virus outbreak in Malaysia. Journal of Clinical Virology. 2003 Apr 1; 26(3): 265-75. DOI: 10.1016/s1386-6532(02)00268-8
15. Rahman SA, Hassan SS, Oliva KJ, Mohamed M, Chang LY, Hassan L, Saad NM, Shoham SA, Mamat ZC, Naim MS, Epstein JH. Characterization of Nipah virus from naturally infected Pteropods vampires’ bats, Malaysia. Emerging Infectious Diseases. 2010 Dec; 16(12): 1990 Doi: 10.3201/eid1612.091790
16. Paton NI, Leo YS, Zaki SR, Auch us AP, Lee KE, Ling AE, Chew SK, Ang B, Rollin PE, Umapathi T, Sang I. Outbreak of Nipah-virus infection among abattoir workers in Singapore. The Lancet. 1999 Oct 9; 354(9186): 1253-6. DOI: 10.1016/S0140-6736(99)04379-2
17. Wahed F, Kader SA, Nessa A, Mahamud MM. Nipah virus: an emergent deadly Paramyxovirus infection in Bangladesh. Journal of Bangladesh Society of Physiologist. 2011; 6(2): 134-9... https://doi.org/10.3329/jbsp.v6i2.9764
18. Rahman MA, Hossain MJ, Sultana S, Homaira N, Khan SU, Rahman M, Gurley ES, Rollin PE, Lo MK, Comer JA, Lowe L. Date palm sap linked to Nipah virus outbreak in Bangladesh, 2008. Vector-Borne and Zoonotic Diseases. 2012 Jan 1; 12(1): 65-72. DOI: 10.1089/vbz.2011.0656
19. Chowdhury S, Khan SU, Cramer G, Epstein JH, Broder CC, Islam A, Peel AJ, Barr J, Dastak P, Wang LF, Luby SP. Serological evidence of henipaviral exposure in cattle, goats and pigs in Bangladesh. Plops Neglected Tropical Diseases. 2014 Nov 20; 8(11): e3302. Doi: 10.1371/journal.pntd.0003302
20. Shariff M. Nipah virus infection: A review. Epidemiology and Infection. 2019; 147: e95. DOI: 10.1017/S0950268819000086
21. Ambat AS, Zubair SM, Prasad N, Pundir P, Rajwar E, Patil DS, Manga P. Nipah virus: A review on epidemiological characteristics and outbreaks to inform public health decision making. J Infect Public Health. 2019 Sep-Oct; 12(5): 634-639. Doi: 10.1016/j.jiph.2019.02.013
22. Yadav PD, Sahay RR, Balakrishnan A, Mohandas S, Radhakrishnan C, Gokhale MD, Balasubramanian R, Abraham P, Gupta N, Sugunan AP, Khobragade R. Nipah virus outbreak in Kerala State, India amidst of COVID-19 pandemic. Frontiers in Public Health. 2022 Feb 17; 10: 818545. Doi: 10.3389/fpubh.2022.818545
23. Ching PK, de Los Reyes VC, Sausalito MN, Tayag E, Columna-Vingo AB, Malbasa Jr FF, Bolo Jr GC, Sever JJ, Eagles D, Playford G, Dreger E. Outbreak of henipaviral infection, Philippines, 2014. Emerging Infectious Diseases. 2015 Feb; 21(2): 328. Doi: 10.3201/eid2102.141433
24. Montgomery JM, Hossain MJ, Gurley E, Carroll DS, Crosier A, Berthe rat E, Asgari N, Furmenty P, Keeler N, Comer J, Bell MR. Risk factors for Nipah virus encephalitis in Bangladesh. Emerging Infectious Diseases. 2008 Oct; 14(10): 1526 Doi: 10.3201/eid1410.060507
25. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Niezgoda M, Rupprecht C, Bresee J, Bierman RF. Nipah virus encephalitis reemergence, Bangladesh. Emerging Infectious Diseases. 2004 Dec; 10(12): 2082. Doi: 10.3201/eid1012.040701
26. Luby SP. The pandemic potential of Nipah virus. Antiviral Research. 2013 Oct 1; 100(1): 38-43. DOI: 10.1016/ j.antiviral.2013.07.011
27. Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, Molla MA, Carroll DS, Ksiazek TG, Rota PA, Lowe L. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerging Infectious Diseases. 2007 Jul; 13(7): 1031. DOI: 10.3201/eid1307.061128
28. Kenmoe S, Demanou M, Bigan JJ, Kengne CN, Modifying AF, Simo FB, Elango S, Sadegh-Mba SA, Nojoom R. Case fatality rate and risk factors for Nipah virus encephalitis: A systematic review and meta-analysis. Journal of Clinical Virology. 2019 Aug 1; 117: 19-26. DOI: 10.1016/j.jcv.2019.05.009
29. Sharma V, Kaushik S, Kumar R, Yadav JP, Kaushik S. Emerging trends of Nipah virus: A review. Reviews in Medical Virology. 2019 Jan; 29(1): e2010. Doi: 10.1002/rmv.2010
30. Yadav PD, Shete AM, Kumar GA, Sar kale P, Sahay RR, Radhakrishnan C, Lakra R, Pardeshi P, Gupta N, Gyanashekar RR, Rajendran VR. Nipah virus sequences from humans and bats during Nipah outbreak, Kerala, India, 2018. Emerging Infectious Diseases. 2019 May; 25(5): 1003. Doi: 10.3201/ eid2505.181076
31. McEntire CR, Song KW, McInnis RP, Rhee JY, Young M, Williams E, Wilbekin LL, Nolan N, Nagy AM, Gluckstein J, Mukerji SS. Neurologic manifestations of the World Health Organization's list of pandemic and epidemic diseases. Frontiers in Neurology. 2021 Feb 22; 12: 634827. DOI: 10.3389/ fneur.2021.634827
32. Stachowiak B, Wingert HM. Nipah virus infects specific subsets of porcine peripheral blood mononuclear cells. Plops One. 2012 Jan 27; 7(1): e30855. Doi: 10.1371/journal.pone.0030855, PMID 22303463
33. Mathieu C, Horvat B. Henipaviral pathogenesis and antiviral approaches. Expert Review of Anti-infective Therapy. 2015 Mar 4; 13(3): 343-54. DOI: 10.1586/14787210.2015.1001838
34. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh WJ, Goldsmith CS. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000 May 26; 288(5470): 1432-5. DOI: 10.1126/science.288.5470.1432
35. Mire CE, Satterfield BA, Geisbert JB, Agans KN, Borisevich V, Yan L, Chan YP, Cross RW, Fenton KA, Broder CC, Geisbert TW. Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: implications for antibody therapy. Scientific Reports. 2016 Aug 3; 6(1): 30916. DOI: 10.1038/srep30916
36. Tiong V, Shu MH, Wong WF, Abubakar S, Chang LY. Nipah virus infection of immature dendritic cells increases its trans endothelial migration across human brain microvascular endothelial cells. Frontiers in Microbiology. 2018 Nov 13; 9: 421816. DOI: 10.3389/fmicb.2018.02747
37. Liu J, Coffin KM, Johnston SC, Babka AM, Bell TM, Long SY, Honko AN, Kuhn JH, Zeng X. Nipah virus persists in the brains of nonhuman primate survivors. JCI Insight. 2019 Jul 7; 4(14). DOI: 10.1172/jci.insight.129629
38. Wong KT, Robertson T, Ong BB, Chong JW, Yaw KC, Wang LF, Alsford AJ, Tannenberg A. Human Hendra virus infection causes acute and relapsing encephalitis. Neuropathology and Applied Neurobiology. 2009 Jun; 35(3): 296-305. DOI: 10.1111/j.1365-2990.2008. 00991.x
39. Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, Wang LF, Mutawalli JJ, Geisbert JB, Bossart KN, Broder CC. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. Plops One. 2010 May 18; 5(5): e10690. DOI: 10.1371/journal.pone.0010690
40. Guillaume V, Wong KT, Looi RY, Georges-Courbet MC, Barrot L, Buckland R, Wild TF, Horvat B. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model. Virology. 2009 May 10; 387(2): 459-65. DOI: 10.1016/j.virol.2009.03.001
41. Abubakar S, Chang LY, Ali AM, Sharifah SH, Yusoff K, Ramrod Z. Isolation and molecular identification of Nipah virus from pigs. Emerging Infectious Diseases. 2004 Dec; 10(12): 2228. Doi: 10.3201/eid1012.040452
42. Mathieu C, Horvat B. Henipaviral pathogenesis and antiviral approaches. Expert Review of Anti-infective Therapy. 2015 Mar 4; 13(3): 343-54. DOI: 10.1586/14787210.2015.1001838
43. Lo MK, Rota PA. The emergence of Nipah virus, a highly pathogenic paramyxovirus. Journal of Clinical Virology. 2008 Dec 1; 43(4): 396-400. DOI: 10.1016/j.jcv.2008.08.007
44. Parashar UD, Sunn LM, Ong F, Mounts AW, Arif MT, Ksiazek TG, Kamaluddin MA, Mustafa AN, Kaur H, Ding LM, Othman G. Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998–1999 outbreak of severe encephalitis in Malaysia. The Journal of Infectious Diseases. 2000 May 1; 181(5): 1755-9 DOI: 10.1086/315457
45. Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sari SA, Wong KT, Abdullah BJ, Chua KB, Lam SK. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. New England Journal of Medicine. 2000 Apr 27; 342(17): 1229-35. Doi: 10.1056/ NEJM200004273421701
46. Chua KB. Nipah virus outbreak in Malaysia. Journal of Clinical Virology. 2003 Apr 1;26(3):265-75.
47. Sharma V, Kaushik S, Kumar R, Yadav JP, Kaushik S. Emerging trends of Nipah virus: A review. Reviews in Medical Virology. 2019 Jan; 29(1): e2010. Doi: 10.1002/rim. 2010
48. Thomas B, Chandran P, Lilabai MP, George B, Sivakumar CP, Jayadev VK, Bindu V, Rajasi RS, Vijayan B, Mohandas A, Hafeez N. Nipah virus infection in Kozhikode, Kerala, South India, in 2018: epidemiology of an outbreak of an emerging disease. Indian Journal of Community Medicine. 2019 Oct 1; 44(4): 383-7. Doi: 10.4103/ijcm.IJCM_198_19
49. Ochan RK, Batra S, Shaikh A, Asad A. Nipah virus-the rising epidemic: a review. Inez Med. 2019 Jun 1; 27(2): 117-27. Shariff M. Nipah virus infection: A review. Epidemiology and Infection. 2019; 147: Doi: 10.3389/fmicb.2021.811157
50. Mazzola LT, Kelly-Cirino C. Diagnostics for Nipah virus: a zoonotic pathogen endemic to Southeast Asia. BMJ Global Health. 2019 Feb 1; 4(Supple 2): e001118. DOI: 10.1136/bmjgh-2018-001118
51. Abdullah S, Tan CT. Henipaviral encephalitis. Handbook of Clinical Neurology. 2014 Jan 1; 123: 663-70. DOI: 10.1016/B978-0-444-53488-0.00032-8
52. Ali R, Mounts AW, Parashar UD, Sahani M, Lye MS, Isa M, Balathevan K, Arif T, Ksiazek TG. Nipah virus infection among military personnel involved in pig culling during an outbreak of encephalitis in Malaysia, 1998-1999. Emerging Infectious Diseases. 2001 Jul 1; 7(4): 759-. DOI: 10.3201/eid0704.010433
53. Lim CC, Lee WL, Leo YS, Lee KE, Chan KP, Ling AE, Oh H, Auch us AP, Paton NI, Hui F, Tambiah PA. Late clinical and magnetic resonance imaging follow up of Nipah virus infection. Journal of Neurology, Neurosurgery and Psychiatry. 2003 Jan 1; 74(1): 131-3. Doi: 10.1016/S0002-9440(10)64493-8
54. Nahar N, Paul RC, Sultana R, Gurley ES, Garcia F, Abedin J, Sumon SA, Banik KC, Acidizing M, Rimi NA, Rahman M. Raw sap consumption habits and its association with knowledge of Nipah virus in two endemic districts in Bangladesh. Plops One. 2015 Nov 9; 10(11): e0142292. Doi: 10.1371/journal.pone.0142292
55. Chakraborty S, Deb B, Barbhuiya PA, Uddin A. Analysis of codon usage patterns and influencing factors in Nipah virus. Virus Research. 2019 Apr 2; 263: 129-38. Doi: 10.1016/j.virusres.2019.01.011
56. Dawes BE, Alvera B, Ikegami T, Juelich T, Smith JK, Zhang L, Park A, Lee B, Komeno T, Furuta Y, Freiberg AN. Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Scientific Reports. 2018 May 15; 8(1): 7604. DOI: 10.1038/s41598-018-25780-3
57. Schaffer O, Hill T, Ikegami T, Juelich TL, Smith JK, Zhang L, Perez DE, Atkins C, Park A, Lawrence WS, Sivasubramanian SK. Experimental infection of Syrian hamsters with aerosolized Nipah virus. The Journal of Infectious Diseases. 2018 Oct 5; 218(10): 1602-10. Doi: 10.1093/indies/jiy357
58. 15. Hassan MZ, Sazid HM, Luby SP, Sturm-Ramirez K, Bhuiyan MU, Rahman MZ, Islam MM, Strother U, Sultana S, Kafi MA, Dastak P. Nipah virus contamination of hospital surfaces during outbreaks, Bangladesh. 2013–2014. Emerging Infectious Diseases. 2018 Jan; 24(1): Doi: 10.3201/eid2401.161758
59. Pallister JA, Klein R, Ark installs R, Haining J, Long F, White JR, Payne J, Feng YR, Wang LF, Broder CC, Middleton D. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months. Virology Journal. 2013 Dec; 10: 1-7. DOI: 10.1186/1743-422X-10-237
60. Wong KT, Shieh WJ, Kumar S, Noraini K, Abdullah W, Guarneri J, Goldsmith CS, Chua KB, Lam SK, Tan CT, Goh KJ. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. The American Journal of Pathology. 2002 Dec 1; 161(6): 2153-67. DOI: 10.1016/S0002-9440(10)64493-8
61. Geisbert TW, Bobb K, Borisevich V, Geisbert JB, Agans KN, Cross RW, Prasad AN, Fenton KA, Yu H, Fouts TR, Broder CC. A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus. NAP. Vaccines. 2021 Feb 8; 6(1): 23. DOI: 10.1038/s41541-021- 00284-w
62. Verma MK, Verma P, Singh S, Gaur P, Siddiqui AH, Pandey S. Nipah virus-infectious agent: An overview. Int. J. Life. Sci. Scienti. Res. eISSN. 2018; 2455(1716): 1716. Doi: 10.1080/01652176.2019.1580827
63. Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang LF. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Research. 2013 Oct 1; 100(1): 8-13. Doi: 10.1016/j.antiviral.2013.06.012
64. Alofi M. Hendra and Nipah infection: emerging paramyxoviruses. Virus Research. 2013 Nov 6; 177(2): 119-26. DOI: 10.1016/j.virusres.2013.08.002
65. o MK, Spengler JR, Welch SR, Harmon JR, Coleman-McCray JD, Scholte FE, Shrivastava-Ranjan P, Montgomery JM, Nichol ST, Weissman D, Spyropoulos CF. Evaluation of a single-dose nucleoside-modified messenger RNA vaccine encoding Hendra virus-soluble glycoprotein against lethal Nipah virus challenge in Syrian hamsters. The Journal of Infectious Diseases. 2020 May 1; 221(Supplement_4): S493-8. DOI: 10.1093/indies/jiz553
66. Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, Geisbert JB, Feng YR, Chan YP, Hickey AC, Broder CC. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Science Translational Medicine. 2012 Aug 8; 4(146): 146ra107-.doi: 10.1126/scitranslmed.3004241
67. Satterfield BA, Dawes BE, Milligan GN. Status of vaccine research and development of vaccines for Nipah virus. Vaccine. 2016 Jun 3; 34(26): 2971-5. DOI: 10.1016/j.vaccine.2015.12.075
68. Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ. Rhabdovirus-based vaccine platforms against henipaviruses. J Virol. 2015; 89(1): 144-54. Doi: 10.1128/JVI.02308-14
69. Poulet H, Minke J, Pardo MC, Juillard V, Nordgren B, Audonnet JC. Development and registration of recombinant veterinary vaccines: the example of the canarypox vector platform. Vaccine. 2007 Jul 26; 25(30): 5606-12. DOI: 10.1016/j.vaccine.2006.11.066
70. Bonaparte MI, Dimitrov AS, Bossart KN, et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci. 2005; 102: 10652–10657. DOI: 10.1073/pnas.0504887102
71. Ploquin A, Szécsi J, Mathieu C, Guillaume V, Barateau V, Ong KC, Wong KT, Cosset FL, Horvat B, Salvetti A. Protection against henipaviral infection by use of recombinant adeno-associated virus–vector vaccines. The Journal of Infectious Diseases. 2013 Feb 1; 207(3): 469-78. DOI: 10.1093/infdis/jis699
72. Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jacquot F, Raoul H, Sato H, Kai C. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge. PloS one. 2013 Mar 14; 8(3): e58414. Doi: 10.1371/journal.pone.0058414
73. Walpita P, Cong Y, Jahrling PB, Rojas O, Postnikova E, Yu S, Johns L, Holbrook MR. A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model. NPJ Vaccines. 2017 Aug 8; 2(1): 21. DOI: 10.1038/s41541-017-0023-7